INX-315
INX-315 is a selective, orally bioavailable CDK2 inhibitor. It demonstrates anticancer activity by inducing cell cycle arrest, senescence, and suppressing E2F-driven transcription, validated in models of CCNE1-amplified cancers and CDK4/6 inhibitor-resistant breast cancer.
Product Specifications
CAS Number
2745060-92-6
Field of Research
Cell Biology
Purity
99.88% (May vary between batches)
Solubility
DMSO:80 mg/mL (187.14 mM) ;10% DMSO+40% PEG300+5% Tween-80+45% Saline:3.3 mg/mL (7.72 mM)
Smiles
O=C1NNC2=CC=3C=NC (=NC3N2C14CCCCC4) NC5=CC=C (C=C5) S (=O) (=O) N
Molecular Formula
C19H21N7O3S
Molecular Weight
427.48
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K3863604 1.0 µg DNA
Il31ra sgRNA CRISPR Lentivector (Mouse) (Target 3)
Sign In for Pricing
View Details 
GTR15169037 1 Vial
Lentiviral mouse A930009A15Rik shRNA (UAS) - Lentiviral mouse A930009A15Rik shRNA (UAS) (25)
Sign In for Pricing
View Details